Association of Vitreous Inflammatory Factors with Diabetic Macular Edema

Ophthalmology

Volumn 116, Issue 1, 2009, Pages 73-79

  Funatsu, Hideharu ^a   Noma, Hidetaka ^a   Mimura, Tatsuya ^b   Eguchi, Shuichiro ^c   Hori, Sadao ^d  

^a Tokyo Women s Medical University   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Eguchi Eye Hospital   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA FOVEA; RETINOPATHY; VITREOUS BODY;

CASE-CONTROL STUDIES; CHEMOKINE CCL2; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; RETROSPECTIVE STUDIES; SERPINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 57949110908     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.09.037     Document Type: Article

References (27)

1. Antcliff R.J., and Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14 (1999) 223-232
2. Jousssen A.M., Poulaki V., Le M.L., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18 (2004) 1450-1452
3. Adamis A.P., and Berman A.J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30 (2008) 65-84
4. Lu M., Perez V.L., Ma N., et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 40 (1999) 1808-1812
5. Qaum T., Xu Q., Joussen A.M., et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42 (2001) 2408-2413
6. Zhang S.X., Wang J.J., Gao G., et al. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 20 (2006) 323-325
7. Meleth A.D., Agron E., Chan C.C., et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46 (2005) 4295-4301
8. Funatsu H., Yamashita H., Ikeda T., et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110 (2003) 1690-1696
9. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98 (1991) 786-806
10. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 98 (1991) 823-833
11. Massin P., Girach A., Erginay A., and Guadric A. Optical coherence tomography: a key to the future management of patients with diabetic macular edema. Acta Ophthalmol Scand 84 (2006) 466-474
12. Abu el-Asrar A.M., Van Damme J., Put W., et al. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Am J Ophthalmol 123 (1997) 599-606
13. Funatsu H., Yamashita H., Sakata K., et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule-1 are related to diabetic macular edema. Ophthalmology 112 (2005) 806-816
14. Funatsu H., Yamashita H., Nakamura S., et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 113 (2006) 294-301
15. Miyamoto K., Khosrof S., Bursell S.E., et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156 (2000) 1733-1739
16. Ishida S., Usui T., Yamashiro K., et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44 (2003) 2155-2162
17. Liu H., Ren J.G., Cooper W.L., et al. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci U S A 101 (2004) 6605-6610
18. Gillies M.C., Sutter F.K.P., Simpson J.M., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113 (2006) 1533-1538
19. Lam D.S.C., Chan C.K.M., Mohamed S., et al. A prospective randomized trial of different doses of intravitreal triamcinolone for diabetic macular oedema. Br J Ophthalmol 91 (2007) 199-203
20. Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114 (2007) 1860-1867
21. Ahmadieh H., Ramezani A., Shoeibi N., et al. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 246 (2008) 483-489
22. Paccola L., Casta R.A., Folgosa M.S., et al. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol 92 (2008) 76-80
23. Edelman J.L., Lutz D., and Castro M.R. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80 (2005) 249-258
24. Penfold P.L., Wen L., Madigan M.C., et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICMA-1) expression of the EVC304 cell line: implications for macular degeneration. Clin Exp Immunol 121 (2000) 458-465
25. Brooks H.L., Caballero S., Newell C.K., et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122 (2004) 1801-1807
26. Mizuno S., Nishiwaki A., Morita H., et al. Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemia retina. Invest Ophthalmol Vis Sci 48 (2007) 2831-2836
27. Tombran-Tink J., Lara N., Apricio S.E., et al. Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cells. Exp Eye Res 78 (2004) 945-955